What is Polypill Products?
Despite significant medical developments in the prevention and treatment of cardiovascular diseases (CVDs), the use of life-saving medicines in low- and middle-income countries (LMICs) is insufficient, and falls short of the optimal level in high-income countries (HICs). The use of three to four vital drugs (aspirin, beta-blockers, diuretics, statins, and ACE inhibitors) will significantly reduce CVD-related mortality, especially in secondary prevention. Combining these medicines (all of which are available as cost-effective generic substitutes) into a single medicine – known as a 'fixed dosage combination' (FDC) or polypill – may increase affordability, access to care, and patient adherence to drug regimens, as well as ease physician medication prescribing. The use of a polypill as the main method of CVD prevention has been suggested as a broad "vaccination" approach to treat asymptomatic persons purely dependent on age or the involvement of risk factors.
The market study is broken down by Type (Aspirin, Beta-Blockers, Diuretics, Statins and ACE-Inhibitors), by Application (Blood Pressure Management and Control Cholesterol Level) and major geographies with country level break-up.
The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth.
Pfizer, Inc. (United States), AstraZeneca plc (United Kingdom), Merck & Co., Inc. (United States), Janssen Pharmaceuticals, Inc. (Johnson & Johnson) (Belgium), Dr. Reddy’s Laboratories Ltd. (India), Cipla, Inc. (India), Cadila Pharmaceuticals (India), Grupo Ferrer International, S.A. (Spain), Gebro Pharma GmbH (Austria) and Gilead Sciences, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Takeda Pharmaceutical Company Limited. (Japan) and Jardine Pharmaceuticals (India).
AdvanceMarketAnalytics has segmented the market of Global Polypill Products market by Type, Application and Region.
On the basis of geography, the market of Polypill Products has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Form, the sub-segment i.e. Capsules will boost the Polypill Products market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Hospital Dispensary will boost the Polypill Products market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Emergence of 3D Printed Polypill Products
- Prevalence of Chronic Diseases and Cardiovascular Disorders
- Technical Progress in Healthcare Technology
- High R&D Investments in Pharmaceutical Industry
- Increasing Demand in Emerging Regions
- Lack of Trained Professionals
- Skewed Player Distribution
Key Target AudiencePolypill Products Manufactures, New Entrants and Investors, Polypill Products Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others
About ApproachDuring this study the evaluation and validation of the market size is done through various sources including primary and secondary analysis. AMA Research & Media follows industrial and regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase